Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02867007
Title KHK2455 Alone and in Combination With Mogamulizumab in Subjects With Locally Advanced or Metastatic Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Kyowa Kirin Pharmaceutical Development, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | FRA

Facility Status City State Zip Country Details
Tampa Florida 33612 United States Details
Albuquerque New Mexico 87106 United States Details
Houston Texas 77030 United States Details
Paris Villejuif 94800 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field